These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. Ambrosy AP; Khan H; Udelson JE; Mentz RJ; Chioncel O; Greene SJ; Vaduganathan M; Subacuis HP; Konstam MA; Swedberg K; Zannad F; Maggioni AP; Gheorghiade M; Butler J Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27140204 [TBL] [Abstract][Full Text] [Related]
9. Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function. Kitai T; Grodin JL; Kim YH; Tang WH Circ Heart Fail; 2017 Feb; 10(2):e003603. PubMed ID: 28130379 [TBL] [Abstract][Full Text] [Related]
10. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. Ambrosy AP; Cerbin LP; Armstrong PW; Butler J; Coles A; DeVore AD; Dunlap ME; Ezekowitz JA; Felker GM; Fudim M; Greene SJ; Hernandez AF; O'Connor CM; Schulte P; Starling RC; Teerlink JR; Voors AA; Mentz RJ JACC Heart Fail; 2017 Jan; 5(1):1-13. PubMed ID: 28034373 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of decreased peripheral congestion detected by Bioelectrical Impedance Vector Analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure. Santarelli S; Russo V; Lalle I; De Berardinis B; Vetrone F; Magrini L; Di Stasio E; Piccoli A; Codognotto M; Mion MM; Castello LM; Avanzi GC; Di Somma S; Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):339-347. PubMed ID: 27073131 [TBL] [Abstract][Full Text] [Related]
12. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134 [TBL] [Abstract][Full Text] [Related]
13. Implications of Using Different Definitions on Outcomes in Worsening Heart Failure. Kelly JP; Cooper LB; Gallup D; Anstrom KJ; Chen HH; Redfield MM; O'Connor CM; Mentz RJ; Hernanadez AF; Felker GM Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514750 [TBL] [Abstract][Full Text] [Related]
14. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). Ambrosy AP; Bhatt AS; Gallup D; Anstrom KJ; Butler J; DeVore AD; Felker GM; Fudim M; Greene SJ; Hernandez AF; Kelly JP; Samsky MD; Mentz RJ Am J Cardiol; 2017 Jul; 120(1):98-105. PubMed ID: 28479167 [TBL] [Abstract][Full Text] [Related]
15. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure. Morris AA; Nayak A; Ko YA; D'Souza M; Felker GM; Redfield MM; Tang WHW; Testani JM; Butler J Circ Heart Fail; 2020 Jul; 13(7):e006827. PubMed ID: 32635768 [TBL] [Abstract][Full Text] [Related]
16. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769 [TBL] [Abstract][Full Text] [Related]
17. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058 [TBL] [Abstract][Full Text] [Related]
18. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial. Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131 [TBL] [Abstract][Full Text] [Related]
19. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Ambrosy AP; Pang PS; Khan S; Konstam MA; Fonarow GC; Traver B; Maggioni AP; Cook T; Swedberg K; Burnett JC; Grinfeld L; Udelson JE; Zannad F; Gheorghiade M; Eur Heart J; 2013 Mar; 34(11):835-43. PubMed ID: 23293303 [TBL] [Abstract][Full Text] [Related]
20. Renal function trajectories and clinical outcomes in acute heart failure. Givertz MM; Postmus D; Hillege HL; Mansoor GA; Massie BM; Davison BA; Ponikowski P; Metra M; Teerlink JR; Cleland JG; Dittrich HC; O'Connor CM; Cotter G; Voors AA Circ Heart Fail; 2014 Jan; 7(1):59-67. PubMed ID: 24281137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]